US grants iPS cell patent to Japanese university pioneer
This article was originally published in Scrip
Executive Summary
Kyoto University has been issued a US patent relating to induced pluripotent stem (iPS) cell technology, in a decision which should help pave the way to the eventual development of regenerative therapies for various disorders.